Redmile Group

GPTKB entity

Statements (59)
Predicate Object
gptkbp:instanceOf Investment Firm
gptkbp:claims Comprehensive analysis
gptkbp:communityPartnerships Collaborates with other firms
gptkbp:customerBase Institutional Investors
Pension Funds
gptkbp:financialPerformance Value investing
Consistent returns
gptkbp:financials Works with various financial advisors
gptkbp:fledgingPeriod Public offerings and acquisitions
gptkbp:focus Healthcare_Investments
gptkbp:founded 2006
gptkbp:founder gptkb:Jeffrey_M._Redmile
gptkbp:funding Approximately $2 billion
Closed-end funds
Regular capital raising efforts
gptkbp:headquarters gptkb:San_Francisco,_California
https://www.w3.org/2000/01/rdf-schema#label Redmile Group
gptkbp:industry Finance
gptkbp:investmentFocus Biotechnology
Research and development
Growth Stage
Fundamental analysis
Long-term capital appreciation
Moderate to high
3-5 years
Long-term value creation
Market volatility
Innovative healthcare solutions
Research-driven approach
Equity and Debt
Experienced professionals
Public and Private Companies
Strong industry connections
Focus on innovation
Provides advisory services to clients
Above market average
Strong management teams
Regular market analysis
Long-term partnerships with companies
Emerging biotech companies
Transformative healthcare solutions
Positive for healthcare sector
Targeting high-growth potential companies.
Life_Sciences
gptkbp:keyPeople gptkb:Jeffrey_M._Redmile
gptkbp:location gptkb:United_States
gptkbp:market gptkb:North_America
Strong presence in healthcare investments
gptkbp:notableEvent Various Pharmaceutical Companies
gptkbp:numberOfEmployees Approximately 20
gptkbp:partnerships Collaborations with other investment firms
gptkbp:performance S&P 500
gptkbp:portfolioCompany Various_Biotech_Firms
gptkbp:regulatoryCompliance gptkb:SEC
Adheres_to_SEC_regulations
gptkbp:reputation Known for expertise in healthcare sector
gptkbp:strategicGoals Expand portfolio in healthcare
gptkbp:type Private Equity Firm
gptkbp:website www.redmilegroup.com